Performance Testing of PCR Assay in Blood Samples for the Diagnosis of Toxoplasmic Encephalitis in AIDS Patients from the French Departments of America and Genetic Diversity of Toxoplasma gondii: A Prospective and Multicentric Study

Abstract

BackgroundToxoplasmic encephalitis in patients with AIDS is a life-threatening disease mostly due to reactivation of Toxoplasma gondii cysts in the brain. The main objective of this study was to evaluate the performance of real-time PCR assay in peripheral blood samples for the diagnosis of toxoplasmic encephalitis in AIDS patients in the French West Indies and Guiana.Methodology/Principal FindingsAdult patients with HIV and suspicion of toxoplasmic encephalitis with start of specific antitoxoplasmic therapy were included in this study during 40 months. The real-time PCR assay targeting the 529 bp repeat region of T. gondii was performed in two different centers for all blood samples. A Neighbor-Joining tree was reconstructed from microsatellite data to examine the relationships between strains from human cases of toxoplasmosis in South America and the Caribbean. A total of 44 cases were validated by a committee of experts, including 36 cases with toxoplasmic encephalitis. The specificity of the PCR assay in blood samples was 100% but the sensitivity was only 25% with moderate agreement between the two centers. Altered level of consciousness and being born in the French West Indies and Guiana were the only two variables that were associated with significantly decreased risk of false negative results with the PCR assay.Conclusion/SignificanceOur results showed that PCR sensitivity in blood samples increased with severity of toxoplasmic encephalitis in AIDS patients. Geographic origin of patients was likely to influence PCR sensitivity but there was little evidence that it was caused by differences in T. gondii strains.Trial RegistrationClinicalTrials.gov NCT00803621

Toxoplasma gondii infection and toxoplasmosis in North Africa: a review

“…The combination between serological and molecular tools for congenital toxoplasmosis diagnosis was only studied by Berredjem et al [31]. The results of this study should be interpreted with caution since using PCR for the detection of the parasite's DNA in peripheral blood samples has low sensitivity and is indicated only in certain cases of immunocompromized patients [5]. Consumption of undercooked meat and the presence of cats in the household were the major risk factors associated with T. gondii infection [31].…”

Genotyping of Toxoplasma gondii in wild boar (Sus scrofa) in southern Italy: Epidemiological survey and associated risk for consumers

“…We carried out a genotypic characterization by MS analysis of the real-time PCR Toxoplasma positive samples. Although there is a fingerprinting method for T. gondii based on 15 MS loci (Ajzenberg et al, 2010), which has been successfully applied to clinical samples such as blood buffy coat and brain tissue (Ajzenberg et al, 2016;Galal, Schares, et al, 2019;Valenzuela-Moreno et al, 2020), our samples were characterized at 5 MS loci based on their low concentration of Toxoplasma genome copies. In fact, one limitation of the 15 MS technique is the requirement of either tachyzoites in cell culture or a minimum quantity of T. gondii genome equivalent copies ranging from 50 to 100 in 5 μl of extracted DNA (Ajzenberg et al, 2010).…”

Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo

“…It has been estimated that the disease may affect one-third of the world's population ( Montoya and Liesenfeld, 2004 ). Although most infections in healthy humans are asymptomatic and self-limiting, severe complications may occur in immunocompromised patients after congenital T. gondii infection ( Ajzenberg et al, 2016 ; Dupont et al, 2012 ).…”